Cargando…

Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells

Mesenchymal stem cell (MSC) therapy is a promising approach to curing bone diseases and disorders. In treating genetic bone disorders, MSC therapy is local or systemic transplantation of isolated and in vitro proliferated MSC rather than bone marrow transplantation. Recent evidence showed that bone...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawai, Hotaka, Oo, May Wathone, Takabatake, Kiyofumi, Tosa, Ikue, Soe, Yamin, Eain, Htoo Shwe, Sanou, Sho, Fushimi, Shigeko, Sukegawa, Shintaro, Nakano, Keisuke, Takeshi, Takarada, Nagatsuka, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020919/
https://www.ncbi.nlm.nih.gov/pubmed/36936364
http://dx.doi.org/10.1002/jbm4.10722
_version_ 1784908366614626304
author Kawai, Hotaka
Oo, May Wathone
Takabatake, Kiyofumi
Tosa, Ikue
Soe, Yamin
Eain, Htoo Shwe
Sanou, Sho
Fushimi, Shigeko
Sukegawa, Shintaro
Nakano, Keisuke
Takeshi, Takarada
Nagatsuka, Hitoshi
author_facet Kawai, Hotaka
Oo, May Wathone
Takabatake, Kiyofumi
Tosa, Ikue
Soe, Yamin
Eain, Htoo Shwe
Sanou, Sho
Fushimi, Shigeko
Sukegawa, Shintaro
Nakano, Keisuke
Takeshi, Takarada
Nagatsuka, Hitoshi
author_sort Kawai, Hotaka
collection PubMed
description Mesenchymal stem cell (MSC) therapy is a promising approach to curing bone diseases and disorders. In treating genetic bone disorders, MSC therapy is local or systemic transplantation of isolated and in vitro proliferated MSC rather than bone marrow transplantation. Recent evidence showed that bone marrow MSC engraftment to bone regeneration has been controversial in animal and human studies. Here, our modified bone marrow transplantation (BMT) method solved this problem. Like routine BMT, our modified method involves three steps: (i) isolation of bone marrow cells from the donor, (ii) whole‐body lethal irradiation to the recipient, and (iii) injection of isolated bone marrow cells into irradiated recipient mice via the tail vein. The significant modification is imported at the bone marrow isolation step. While the bone marrow cells are flushed out from the bone marrow with the medium in routine BMT, we applied the enzymes’ (collagenase type 4 and dispase) integrated medium to wash out the bone marrow cells. Then, cells were incubated in enzyme integrated solution at 37°C for 10 minutes. This modification designated BMT as collagenase‐integrated BMT (c‐BMT). Notably, successful engraftment of bone marrow MSC to the new bone formation, such as osteoblasts and chondrocytes, occurs in c‐BMT mice, whereas routine BMT mice do not recruit bone marrow MSC. Indeed, flow cytometry data showed that c‐BMT includes a higher proportion of LepR(+), CD51(+), or RUNX2(+) non‐hematopoietic cells than BMT. These findings suggested that c‐BMT is a time‐efficient and more reliable technique that ensures the disaggregation and collection of bone marrow stem cells and engraftment of bone marrow MSC to the recipient. Hence, we proposed that c‐BMT might be a promising approach to curing genetic bone disorders. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
format Online
Article
Text
id pubmed-10020919
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-100209192023-03-18 Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells Kawai, Hotaka Oo, May Wathone Takabatake, Kiyofumi Tosa, Ikue Soe, Yamin Eain, Htoo Shwe Sanou, Sho Fushimi, Shigeko Sukegawa, Shintaro Nakano, Keisuke Takeshi, Takarada Nagatsuka, Hitoshi JBMR Plus Research Articles Mesenchymal stem cell (MSC) therapy is a promising approach to curing bone diseases and disorders. In treating genetic bone disorders, MSC therapy is local or systemic transplantation of isolated and in vitro proliferated MSC rather than bone marrow transplantation. Recent evidence showed that bone marrow MSC engraftment to bone regeneration has been controversial in animal and human studies. Here, our modified bone marrow transplantation (BMT) method solved this problem. Like routine BMT, our modified method involves three steps: (i) isolation of bone marrow cells from the donor, (ii) whole‐body lethal irradiation to the recipient, and (iii) injection of isolated bone marrow cells into irradiated recipient mice via the tail vein. The significant modification is imported at the bone marrow isolation step. While the bone marrow cells are flushed out from the bone marrow with the medium in routine BMT, we applied the enzymes’ (collagenase type 4 and dispase) integrated medium to wash out the bone marrow cells. Then, cells were incubated in enzyme integrated solution at 37°C for 10 minutes. This modification designated BMT as collagenase‐integrated BMT (c‐BMT). Notably, successful engraftment of bone marrow MSC to the new bone formation, such as osteoblasts and chondrocytes, occurs in c‐BMT mice, whereas routine BMT mice do not recruit bone marrow MSC. Indeed, flow cytometry data showed that c‐BMT includes a higher proportion of LepR(+), CD51(+), or RUNX2(+) non‐hematopoietic cells than BMT. These findings suggested that c‐BMT is a time‐efficient and more reliable technique that ensures the disaggregation and collection of bone marrow stem cells and engraftment of bone marrow MSC to the recipient. Hence, we proposed that c‐BMT might be a promising approach to curing genetic bone disorders. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. John Wiley & Sons, Inc. 2023-02-11 /pmc/articles/PMC10020919/ /pubmed/36936364 http://dx.doi.org/10.1002/jbm4.10722 Text en © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Kawai, Hotaka
Oo, May Wathone
Takabatake, Kiyofumi
Tosa, Ikue
Soe, Yamin
Eain, Htoo Shwe
Sanou, Sho
Fushimi, Shigeko
Sukegawa, Shintaro
Nakano, Keisuke
Takeshi, Takarada
Nagatsuka, Hitoshi
Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells
title Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells
title_full Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells
title_fullStr Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells
title_full_unstemmed Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells
title_short Enzyme‐Cleaved Bone Marrow Transplantation Improves the Engraftment of Bone Marrow Mesenchymal Stem Cells
title_sort enzyme‐cleaved bone marrow transplantation improves the engraftment of bone marrow mesenchymal stem cells
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020919/
https://www.ncbi.nlm.nih.gov/pubmed/36936364
http://dx.doi.org/10.1002/jbm4.10722
work_keys_str_mv AT kawaihotaka enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells
AT oomaywathone enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells
AT takabatakekiyofumi enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells
AT tosaikue enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells
AT soeyamin enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells
AT eainhtooshwe enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells
AT sanousho enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells
AT fushimishigeko enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells
AT sukegawashintaro enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells
AT nakanokeisuke enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells
AT takeshitakarada enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells
AT nagatsukahitoshi enzymecleavedbonemarrowtransplantationimprovestheengraftmentofbonemarrowmesenchymalstemcells